Top View
- Converting Enzyme (TACE&Sol;ADAM17)
- A Systematic Study of Modulation of ADAM-Mediated Ectodomain Shedding by Site-Specific O-Glycosylation
- The Role of the Metalloproteases ADAM8, 9, 10 and 17 in Leukocyte Migration in Vitro
- ADAM17 Is a Tumor Promoter and Therapeutic Target in Western Diet
- Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation
- ADAM10 Inhibition of Human CD30 Shedding Increases Specificity of Targeted Immunotherapy in Vitro
- Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17
- Chemotherapy-Induced Activation of ADAM-17: a Novel Mechanism of Drug Resistance in Colorectal Cancer
- To Measure ADAM10 and ADAM17 Sheddase Activities in Cell and Tissue Lysates
- Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer
- Regulated ADAM17-Dependent EGF Family Ligand Release by Substrate-Selecting Signaling Pathways
- Renin-Angiotensin System Inhibitors and COVID-19: Potential Therapeutics Rather Than Perpetrators
- ADAM17 Limits the Expression of CSF1R on Murine Hematopoietic Progenitors Amy M
- Endothelial Cell Malignancies: New Insights from the Laboratory and Clinic
- Characterization of NUMB As a Regulator of Anaplastic Lymphoma Kinase
- Insulin Treatment Attenuates Renal ADAM17 and ACE2 Shedding in Akita Diabetic Mice
- ADAM17: an Emerging Therapeutic Target for Lung Cancer
- Acute Myeloid Leukemia Targets for Bispecific Antibodies
- TNF-␣) Processing in Adipocytes and Increased Expression of Transmembrane TNF-␣ in Obesity Haiyan Xu,1 K
- Proteolytic Cleavage of Receptor Tyrosine Kinases
- Adipose Dipeptidyl Peptidase-4 and Obesity Correlation with Insulin Resistance and Depot-Specific Release from Adipose Tissue in Vivo and in Vitro
- SARS-Cov-2 Evolutionary Adaptation Toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus–Host Interaction
- The Knockout Punch for HER2 Positive Breast Cancer: Addition of an ADAM10 Inhibitor to the Combination Therapy of Trastuzamab and Lapatinib Marcia L
- Expression of CD13/Aminopeptidase N by Synovial Fibroblasts: Novel Roles in the Pathogenesis of Rheumatoid Arthritis
- Shedding Α TNF- Compensatory Increases in ADAM17 and (ADAM
- Structural and Functional Analyses of the Shedding Protease ADAM17 In
- Novel Targeted Therapies of T Cell Lymphomas Katarzyna Iżykowska, Karolina Rassek, Dorota Korsak and Grzegorz K
- The Physiological Relevance of ADAM17 in Colon Cancer Development
- Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell
- ADAM17 Regulates Epidermal Growth Factor Receptor Expression Through the Activation of Notch1 in Non–Small Cell Lung Cancer
- To Measure ADAM10 and ADAM17 Sheddase
- Bites, DARTS, Bikes and Trikes—Are Antibody Based Therapies Changing the Future Treatment of AML?
- ACE2) and Neprilysin (NEP) in Type 2 Diabetic Patients
- In Turn Downregulates ADAM17 by Internalization in Acute Myeloid Leukaemia Cells Sandrine Bouchet, Ruoping Tang, Fanny Fava, Ollivier Legrand, Brigitte Bauvois